Altimmune, Inc.
Nasdaq · CIK 0001326190 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$5,000
Operating Income
$-24.2M
Net Income
$-22.6M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $5,000 | - | - |
| Operating Income | $-24.2M | - | - |
| Net Income | $-22.6M | - | - |
| Eps Basic | -0.18 | - | - |
| Eps Diluted | -0.18 | - | - |
| Cash And Equivalents | $97.6M | - | - |
| Total Assets | $335.6M | - | - |
| Total Liabilities | $51.6M | - | - |
| Shareholders Equity | $284.0M | - | - |
| Operating Cash Flow | $-20.9M | - | - |
| Capital Expenditures | $21,000 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Altimmune, Inc. | 2026-05-13 | 0001326190-26-000040 |
| 4 | Altimmune, Inc. | 2026-04-06 | 0001409939-26-000002 |
| 4 | Altimmune, Inc. | 2026-04-01 | 0001251779-26-000007 |
| 4 | Altimmune, Inc. | 2026-04-01 | 0001698665-26-000005 |
| 4 | Altimmune, Inc. | 2026-03-09 | 0001251779-26-000005 |
| 4 | Altimmune, Inc. | 2026-03-09 | 0001698665-26-000003 |
| 10-K | Altimmune, Inc. | 2026-03-06 | 0001326190-26-000018 |
| 4 | Altimmune, Inc. | 2026-02-03 | 0001705905-26-000006 |
| 4 | Altimmune, Inc. | 2026-02-02 | 0001515813-26-000006 |
| 4 | Altimmune, Inc. | 2026-02-02 | 0001960780-26-000008 |
| 4 | Altimmune, Inc. | 2026-01-29 | 0001705905-26-000004 |
| 4 | Altimmune, Inc. | 2026-01-29 | 0001960780-26-000006 |
| 4 | Altimmune, Inc. | 2026-01-29 | 0001515813-26-000004 |
| 4 | Altimmune, Inc. | 2026-01-27 | 0001960780-26-000004 |
| 4 | Altimmune, Inc. | 2026-01-27 | 0001515813-26-000002 |
| 4 | Altimmune, Inc. | 2026-01-27 | 0001705905-26-000002 |
| 4 | Altimmune, Inc. | 2026-01-09 | 0001743611-26-000002 |
| 4 | Altimmune, Inc. | 2026-01-05 | 0001555132-26-000002 |
| 4 | Altimmune, Inc. | 2026-01-05 | 0001960780-26-000002 |
| 4 | Altimmune, Inc. | 2025-12-29 | 0001527204-25-000005 |
| 4 | Altimmune, Inc. | 2025-12-23 | 0001409939-25-000005 |
| 4 | Altimmune, Inc. | 2025-12-22 | 0001698665-25-000005 |
| 4 | Altimmune, Inc. | 2025-11-12 | 0001251779-25-000006 |
| 10-Q | Altimmune, Inc. | 2025-11-06 | 0001326190-25-000064 |
| 4 | Altimmune, Inc. | 2025-09-29 | 0001104659-25-094493 |
| 10-Q | Altimmune, Inc. | 2025-08-12 | 0001326190-25-000040 |
| 4 | Altimmune, Inc. | 2025-08-04 | 0001104659-25-073629 |
| 4 | Altimmune, Inc. | 2025-08-04 | 0001104659-25-073627 |
| 4 | Altimmune, Inc. | 2025-08-04 | 0001104659-25-073624 |